[go: up one dir, main page]

FI884070A0 - Rytmstoerningar foerhindrande medel. - Google Patents

Rytmstoerningar foerhindrande medel.

Info

Publication number
FI884070A0
FI884070A0 FI884070A FI884070A FI884070A0 FI 884070 A0 FI884070 A0 FI 884070A0 FI 884070 A FI884070 A FI 884070A FI 884070 A FI884070 A FI 884070A FI 884070 A0 FI884070 A0 FI 884070A0
Authority
FI
Finland
Prior art keywords
return
medicinal product
sulphonamide
chem
formula
Prior art date
Application number
FI884070A
Other languages
English (en)
Other versions
FI89909B (fi
FI89909C (fi
FI884070L (fi
Inventor
John Edmund Arrowsmith
Peter Edward Cross
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of FI884070A0 publication Critical patent/FI884070A0/fi
Publication of FI884070L publication Critical patent/FI884070L/fi
Publication of FI89909B publication Critical patent/FI89909B/fi
Application granted granted Critical
Publication of FI89909C publication Critical patent/FI89909C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
FI884070A 1987-09-05 1988-09-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sulfonamidderivat och mellanprodukter FI89909C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8720910 1987-09-05
GB878720910A GB8720910D0 (en) 1987-09-05 1987-09-05 Antiarrhythmic agents
CA567186 1988-05-19
CA000567186A CA1291164C (en) 1987-09-05 1988-05-19 Indane sulfonamide antiarrythmic agents

Publications (4)

Publication Number Publication Date
FI884070A0 true FI884070A0 (fi) 1988-09-02
FI884070L FI884070L (fi) 1989-03-06
FI89909B FI89909B (fi) 1993-08-31
FI89909C FI89909C (fi) 1993-12-10

Family

ID=25671902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884070A FI89909C (fi) 1987-09-05 1988-09-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sulfonamidderivat och mellanprodukter

Country Status (13)

Country Link
EP (1) EP0307121B1 (fi)
JP (1) JP2653850B2 (fi)
AT (1) ATE73773T1 (fi)
CA (2) CA1291164C (fi)
DD (1) DD281596A5 (fi)
DE (1) DE3869289D1 (fi)
DK (1) DK488588A (fi)
ES (1) ES2032972T3 (fi)
FI (1) FI89909C (fi)
GB (1) GB8720910D0 (fi)
GR (1) GR3004627T3 (fi)
IE (1) IE61505B1 (fi)
PT (1) PT88406B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
ES2157204T3 (es) * 1991-04-17 2001-08-16 Upjohn Co Derivados de (s)-3-fenilpiperidina sustituidos, su preparacion y uso como antagonistas de autorreceptores de dopamina.
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
DE4335718A1 (de) * 1993-10-20 1995-04-27 Merck Patent Gmbh Cyclische Aminderivate
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
WO2003049736A1 (en) 2001-12-11 2003-06-19 Sepracor, Inc. 4-substituted piperidines, and methods of use thereof
GB2543296A (en) * 2015-10-13 2017-04-19 Indivior Uk Ltd Dopamine D3 receptor antagonists having a morpholine moiety
WO2023079128A1 (en) * 2021-11-08 2023-05-11 F. Hoffmann-La Roche Ag Catalytic hydrogenation of aromatic nitro compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0140359B1 (en) * 1983-11-02 1989-01-25 Beecham Group Plc Morpholine derivatives
EP0164865B1 (en) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use

Also Published As

Publication number Publication date
EP0307121B1 (en) 1992-03-18
DD281596A5 (de) 1990-08-15
PT88406B (pt) 1992-10-30
GR3004627T3 (fi) 1993-04-28
FI89909B (fi) 1993-08-31
PT88406A (pt) 1989-07-31
CA1291164C (en) 1991-10-22
IE882665L (en) 1989-03-05
EP0307121A1 (en) 1989-03-15
JPS6471856A (en) 1989-03-16
FI89909C (fi) 1993-12-10
DE3869289D1 (de) 1992-04-23
ES2032972T3 (es) 1993-03-01
DK488588D0 (da) 1988-09-02
CA1320726C (en) 1993-07-27
IE61505B1 (en) 1994-11-02
ATE73773T1 (de) 1992-04-15
GB8720910D0 (en) 1987-10-14
FI884070L (fi) 1989-03-06
DK488588A (da) 1989-03-06
JP2653850B2 (ja) 1997-09-17

Similar Documents

Publication Publication Date Title
NL350044I2 (nl) Guanidinederivaten, de bereiding ervan en insekticiden
FI884070A0 (fi) Rytmstoerningar foerhindrande medel.
IL85822A0 (en) Benzazepine sulfonamides and pharmaceutical compositions containing them
GB8706662D0 (en) Anti-arrhythmia agents
ATE58732T1 (de) Antiarrhythmische mittel.
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER LIMITED